Enzon Pharmaceuticals, Inc.
General ticker "ENZN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.4M (TTM average)
Enzon Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -20.0%.
Estimated limits based on current volatility of 4.1%: low 0.04$, high 0.04$
Factors to consider:
- Total employees count: 123 as of 1995
- Top business risk factors: Acquisition/divestiture risks, Change of control provisions, Economic downturns and volatility, Operational and conduct risks, Regulatory and compliance
- Current price 51.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.09$, 0.23$]
- 2025-12-31 to 2026-12-31 estimated range: [0.08$, 0.20$]
Financial Metrics affecting the ENZN estimates:
- Positive: with PPE of 16.9 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 6.38 <= 18.93
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: 6.82 < Operating cash flow per share per price, % of 8.55
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: Industry earnings per price (median), % of -16.34 <= 0
Short-term ENZN quotes
Long-term ENZN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.03MM | $0.00MM | $0.03MM |
| Operating Expenses | $1.06MM | $1.04MM | $1.35MM |
| Operating Income | $-1.03MM | $-1.04MM | $-1.33MM |
| Non-Operating Income | $0.65MM | $2.26MM | $2.45MM |
| Income(Loss) | $-0.39MM | $1.22MM | $1.12MM |
| Taxes | $-0.20MM | $-0.16MM | $0.35MM |
| Profit(Loss)* | $-0.19MM | $0.10MM | $0.78MM |
| Stockholders Equity | $45.89MM | $45.99MM | $3.01MM |
| Assets | $47.59MM | $47.70MM | $47.17MM |
| Operating Cash Flow | $-0.66MM | $1.30MM | $1.12MM |
| Financing Cash Flow | $0.00MM | $-1.27MM | $-1.27MM |
| Earnings Per Share** | $-0.00 | $0.00 | $0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.